Solventum Corp (SOLV)

↓ Download CSV

CIK 0001964738 · NYSE · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Solventum Corp reported revenue of $8.32B, up 0.9% from the prior year. The company was profitable, with a net margin of 18.7% and a gross margin of 53.5%. It held $14.29B in total assets against $9.24B in total liabilities.

Key ratios (FY2025)

53.5%
Gross margin
26.2%
Operating margin
18.7%
Net margin
30.8%
Return on equity
+0.9%
Revenue growth (YoY)
Metric (FY)20252024202320222021
Revenue$8.32B$8.25B$8.20B$8.13B
Gross Profit$4.45B$4.59B$4.69B$4.70B
Operating Income$2.18B$1.04B$1.69B$1.69B
Net Income$1.56B$479.00M$1.35B$1.34B
EPS (Diluted)$8.88$2.76$7.79$7.78
Total Assets$14.29B$14.46B$13.94B
Total Liabilities$9.24B$11.50B$2.28B
Shareholders' Equity$5.05B$2.96B$11.67B$11.74B$12.06B
Cash & Equivalents$878.00M$762.00M$194.00M
Operating Cash Flow$369.00M$1.19B$1.92B$1.68B
Capital Expenditures$379.00M$380.00M$290.00M$251.00M
Shares Outstanding175.30M173.70M172.70M172.70M